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Aims Optimal exercise programming of cardiac resynchronization therapy (CRT) devices is unknown. We
aimed to: (i) investigate variations in optimal atrioventricular (AV) and interventricular (VV) delays from
rest to exercise, assessed by both echocardiography and an automated intracardiac electrogram (IEGM)
method; (ii) evaluate the acute haemodynamic impact of CRToptimization performed during exercise.
Methods and results Twenty-four heart failure patients, previously implanted with a CRT deﬁbrillator,
underwent AV and VV delay optimization, by echocardiography and IEGM methods, both at rest and
during supine bicycle exercise. Rest-to-exercise variations in optimal VV delay were observed in 58%
of patients. Conversely, optimal AV delay did not change during exercise compared with rest. Substan-
tial agreement of AV and VV delays was observed between both the optimization methods. Exercise
optimization of VV delay by either method improved intraventricular dyssynchrony and increased
aortic velocity time integral compared with the resting setting (P , 0.001).
Conclusion In patients implanted with a CRT device, optimal VV delay varied considerably from rest to
exercise, while AV delay did not change. Re-assessment of the optimal pacing conﬁguration during
supine exercise, by echocardiography as well as IEGM methods, yielded an additional haemodynamic
beneﬁt to that provided by resting optimization.
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Introduction
Cardiac resynchronization therapy (CRT) is a valuable treat-
ment for patients with moderate to severe heart failure and
ventricular conduction delay.
1,2 CRT has been shown to
improve resting and exercise left ventricular (LV) function
by reducing inter- and intraventricular dyssynchrony.
3,4
Resynchronization of left (LV) and right ventricular (RV) con-
traction is usually achieved by biventricular pacing, as the
effects of LV pacing alone are still under investigation.
5
During biventricular pacing, individual optimization of pace-
maker settings may further improve CRT beneﬁcial effects
by tailoring the sequence of ventricular activation.
6–11
Contemporary CRT devices permit programming of both
the atrioventricular (AV) and the interventricular (VV)
delay. Multiple studies have shown that echocardiographic
optimization of AV and VV delays can improve cardiac
outputbyincreasingdiastolicﬁllingtimeandreducingLVdys-
synchrony.
6–11 Nevertheless, routine performance of echo-
cardiographic optimization is limited by several factors,
including time requirement and lack of a standard protocol.
A novel intracardiac electrogram (IEGM) method has there-
fore been recently developed in order to simplify the optim-
ization procedure. The IEGM method is based on the analysis
of atrial intrinsic depolarization and interventricular conduc-
tion delay (IVCD) by an automated programmer algorithm.
This new method has been under evaluation as an alternative
to the standard echocardiographic optimization.
12,13
Currently, individual optimization of a CRT device is per-
formed by echocardiography only during resting conditions.
However, exercise may induce dynamic changes in LV acti-
vation pattern in heart failure patients.
14 These changes
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cause exercise-induced variations in haemodynamic par-
ameters.
14 To date, limited information is available on
optimal CRT programming during exercise,
3,15 and it is still
unknown whether CRT optimization performed during exer-
cise may provide further haemodynamic beneﬁts compared
with resting optimization.
The aim of our study was: (i) to investigate the effects of
exercise on optimal AV and VV delays, assessed by both
echocardiography and the IEGM methods; (ii) to compare
both the optimization methods with regard to the rec-
ommended AV and VV delays. In addition, we sought to
evaluate the impact of CRT optimization on acute haemo-
dynamic variables performed both at rest and during
exercise.
Methods
Patient selection
All patients, who had been implanted according to the current
guidelines
16 with a St. Jude Medical CRT deﬁbrillator between
November 2003 and March 2007 at Karolinska University Hospital,
were screened for enrolment. Patients were excluded from the
study if they had: (i) complete AV block; (ii) atrial ﬁbrillation; (iii)
suboptimal echocardiographic images; (iv) inability to perform
supine exercise echocardiography. Enrolment began in September
2006 and ended in April 2007. Patient characteristics were collected
through clinical examination and medical record review at the time
of inclusion in the study. The local Ethics Committee approved the
study protocol and all patients provided written informed consent
to participation.
Study protocol
All patients ﬁrst underwent AVand VV delay optimization under rest
conditions. The optimization was carried out according to both the
IEGM- and the echocardiogram-based method in a random order.
The patients then performed two consecutive supine bicycle exer-
cise tests (exercise A and exercise B). For this purpose, we used a
bicycle ergometer with a possibility of left lateral tilt to facilitate
ultrasound measurements (Ergoline GmbH & Co KG, Bitz,
Germany). The workload was kept constant at 30 W during the
test. Each exercise was performed during spontaneous rhythm
until a steady 20-beat increase in heart rate was achieved. There-
after, AV and VV delay optimization was carried out according to
the IEGM (exercise A) or the echocardiogram method (exercise B).
Exercises A and B were performed in a random order, and a
resting period of at least 15 min was allowed in between for com-
plete recovery of the patient and a decrease in heart rate to the
resting values. Heart rate was constantly monitored throughout
the examination. Right arm blood pressure was measured at rest
and at the end of the exercise.
Echocardiographic optimization
Transthoracic Doppler echocardiography was performed using a
Vivid 7 system (Vingmed-General Electric, Horten, Norway)
equipped with a phased-array 3.5 MHz transducer (Doppler fre-
quency 5.0–3.5 MHz). Echocardiographic images were recorded
during spontaneous rhythm and sequential biventricular pacing
with different pacing conﬁgurations. Acquisitions were digitally
stored on a dedicated server and post-processed using a workstation
(GE EchoPAC sw only, version 5.1.0, Horten, Norway). A standard
evaluation of LV volumes was performed according to Simpson’s
rule and LV ejection fraction was calculated for each patient.
Pulsed-wave Doppler was used to record aortic ﬂow velocities in
the LVoutﬂow tract (LVOT). At rest AVand VV delays were optimized
by on-line analysis of the LVOT velocity time integral (VTI).
9,15,17,18
Care was taken to maintain the same transducer position and
sample volume location throughout the recordings. LVOT VTI was
averaged over at least three consecutive cardiac cycles, in order
to reduce the variability due to respiration. AV delay optimization
was performed during atrial triggered simultaneous biventricular
pacing. AV delays were analysed between 80 and 180 ms, with
steps of 20 ms. Paced AV delay was calculated as the sum of
sensed AV delay and an off-set factor of 50 ms or lower, in order
to ensure atrial-synchronized ventricular pacing. VV delay optimiz-
ation was performed after AV delay programming. We analysed VV
intervals ranging from 240 ms (LV pacing ﬁrst) to þ40 ms (RV
pacing ﬁrst), with steps of 20 ms. An equilibrium period of
1–2 min was maintained between echocardiographic recordings to
allow haemodynamic stabilization. Optimal AV and VV delays were
determined by the highest mean value of LVOT VTI.
9,15–18
Intraventricular dyssynchrony was assessed by colour-coded tissue
velocity imaging (TVI) during spontaneous rhythm and sequential
biventricular pacing with IEGM- and echo-optimized delays. TVI
images were obtained in the apical four-chamber view at a frame
rate .100 frames/s. Sample volumes were placed in the basal por-
tions of the septum and LV lateral wall and the time from the QRS
onset to the peak systolic myocardial velocity at each point was
measured. The septal-to-lateral delay in peak systolic velocities
was calculated as a measure of intraventricular dyssynchrony.
19
Off-line analysis included LVOT VTI measurement during exercise
and intraventricular dyssynchrony assessment at rest and during
exercise. All images were recorded by an experienced sonographer
and analysed by one skilled blinded operator. The mean value of at
least three consecutive cardiac cycles was taken for each echocar-
diographic variable. Intraobserver and interobserver variability, cal-
culated in 10 patients and expressed by the coefﬁcient of variation
(%) between two assessments were, respectively, 2.9 and 4.0% for
AV delay, 5.7 and 6.6% for VV delay.
Intracardiac electrogram optimization
The IEGM optimization was performed according to an automated
programmer algorithm which calculates the optimal AV and then
VV delays from measurements performed during speciﬁc sensing
and pacing tests (QuickOptTM, St Jude Medical, St Paul, MN,
USA).
12,13
In synthesis, mitral valve closure is estimated by measuring the
interatrial conduction time (P-wave duration).
20 The IEGM P-wave
duration represents the sum of right and left atrial activation. The
algorithm utilizes this measurement to calculate the optimal
sensed and paced AV delays, with the goal of maximizing preload
and allowing for proper timing of mitral valve closure. For VV
delay optimization, paced and sensed tests are performed to
characterize the conduction properties of the ventricles. Onset of
isovolumic contraction is measured using the peak of the R wave.
IVCDs are calculated by evaluating simultaneous RV and LV IEGMS
and measuring the time between the peaks of the R waves. The
goal is to time the RV and LV activation, so that the paced wave
fronts can resynchronize ventricular contraction.
More in detail, for AV delay optimization the algorithm measures
the width of the atrial intrinsic depolarization and adds an off-set
factor of 30 ms if the intrinsic depolarization is greater than or
equal to 100 ms, or 60 ms if the intrinsic depolarization is
,100 ms. The off-set factor makes it possible to deliver ventricular
pacing after the completion of atrial electrical activation and mech-
anical contraction. Paced AV delay is calculated as the sum of
sensed AV delay and the pacing latency (50 ms). The VV delay algor-
ithm includes two components: the conduction delay (D) and the
correction term (e). D is the difference between the time of
peak intrinsic activation on the LV lead (RLV) and the RV lead (RRV)
[D ¼ RLV 2 RRV]. The correction term (e) is the difference in the
IVCD between two ventricular paced propagation waveform time
delays. IVCD.RL is the interventricular conduction delay when the
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the interventricular conduction delay when the LV lead is paced
and the delay is sensed at the RV lead. During the test, each
chamber is paced with a short AV delay to ensure the absence
of fusion. The correction term equation is e ¼ IVCD.LR 2 IVCD.RL.
The IEGM optimal VV delay is calculated as VV ¼ 0.5 (D þ e). If
VV .0, the LV is activated ﬁrst; if VV ,0, the RV is activated ﬁrst.
After performing the automated programmer-based optimization,
LVOT VTI and LV dyssynchrony were assessed by echocardiography at
the IEGM recommended delays. Both at rest and during exercise, the
values of LVOT VTI and LV dyssynchrony at the optimal echo and
IEGM settings were compared, and related to those measured
during spontaneous rhythm (without biventricular stimulation).
The reproducibility of the IEGM method, calculated in 10 patients
and expressed by the coefﬁcient of variation (%) between two
separate measurements, was good for all the parameters (3.3% for
AV delay; 6.5% for VV delay).
Statistical analysis
Continuous data are presented as mean and standard deviation or as
median and inter-quartile range (P25; P75). The data were analysed
using a one-way repeated measures ANOVA with ‘methods’ (spon-
taneous, IEGM, and echo) as the within-subjects variable. In the
event of inhomogeneous variances and covariances, the MIXED in
SASw procedure was used. The covariance structure unstructured
(UN) was then performed. If the F ratio for the factor ‘method’
was signiﬁcant, post hoc contrasts between mean values were per-
formed and 95% CI were calculated for the mean differences. Since
the distribution of some variables was positively skewed, log-
transformation was performed before the analyses. For dependent
samples t-test and sign test were used to analyse data variation
from rest to exercise during spontaneous rhythm and biventricular
pacing. P , 0.05 was considered statistically signiﬁcant. Corre-
lations between continuous variables were calculated with
Pearson correlation coefﬁcient. Spearman rank correlation coefﬁ-
cient was calculated for continuous variables that are not normally
distributed. Weighted-Kappa with quadratic weights was used to
assess the agreement between methods, and between rest and
exercise measurements of non-continuous pacemaker parameters.
Results
A total of 63 patients were screened for the study. Thirty-
nine patients were not enrolled because of atrial ﬁbrillation
(n ¼ 11), complete AV block (n ¼ 5), inability to perform an
exercise test (n ¼ 10), suboptimal echocardiographic images
(n ¼ 5), and refusal to participate in the study (n ¼ 8). The
remaining 24 patients were included in the study. Patient
characteristics at the time of enrolment are presented
in Table 1. The mean time of CRT treatment was 10+
2 months. Thirteen patients (54%) were in NYHA class II, 11
(46%) in class III. Accordingly, diuretics were taken only by
19 patients (79%). All patients completed the study protocol
without chest pain or any complication. No signiﬁcant differ-
ences in heart rate and blood pressure were observed
between exercises A and B. Both exercises induced a
similar percentage increase in the rate pressure product
(þ58+27% vs. þ47+19%, P ¼ 0.11), and in heart rate
(þ38+16% vs. þ34+9%, P ¼ 0.22).
Echocardiographic optimization of atrioventricular
and interventricular delay at rest
and during exercise
Echo-optimized AV and VV delays, at rest and during supine
exercise are presented in Table 2. The optimal AV delay at
rest, as assessed by echocardiography, was 140 ms (120–
155 ms). No signiﬁcant difference in AV delay was observed
between rest and exercise (P ¼ 0.26).
Median VV delay at rest was 0 ms (0–0 ms). As reported in
Table 3, the optimal pacing conﬁguration at rest was
achieved by simultaneous biventricular pacing in 17 patients
(71%), LV pre-activation in ﬁve patients (21%), and RV pre-
activation in two patients (8%). In the RV pre-activated
patients, the underlying aetiology was ischaemic heart
disease with intraventricular conduction delay, and the LV
lead placement was mid-posterolateral and lateral. Exercise
induced a change in VV delay programming in 14 patients
(58%). Rest–exercise variations in optimal VV delay ranged
from 20 to 60 ms, with a median value of 20 ms. We could
not ﬁnd any concordance between rest and exercise
optimal VV delays (weighted Kappa ¼ 20.05).
Intracardiac electrogram optimization of
atrioventricular and interventricular delay
at rest and during exercise
Optimized AV and VV delays, according to the IEGM method,
are presented in Tables 2 and 3. No signiﬁcant changes in
AV delays were observed between rest and exercise
(P ¼ 0.43).
Median VV delay at rest was 0 ms (220 to 10 ms). During
exercise, VV delay programming changed in 13 patients
(54%), with variations ranging from 5 to 70 ms (median
10 ms). In 10 of these patients, changes in optimal VV
delay were detected by both the echocardiogram and the
IEGM method. We could not ﬁnd any predictor of rest–exer-
cise variations in VV delay, determined by either method.
Comparison of atrioventricular and interventricular
delay optimization by echo vs. intracardiac
electrogram
For each delay, the agreement between the
echocardiogram- and the IEGM-based method, at rest and
during exercise, is reported as Kappa values in Table 2.
Table 1 Characteristics of the study population at the time of
enrolment (n ¼ 24)
Age (years) 63+9
Sex (M/F) 19/5
Aetiology (ischaemic/non-ischaemic,%) 58/42
NYHA class 2.5+0.5
QRS duration (ms) 183+46
Mean time of CRT treatment (months) 10+8
LV lead position (lateral/posterolateral, n) 12/12
RV lead position (septal/apical, n) 5/19
LVEDV (mL) 185+65
LVESV (mL) 120+58
LVEF (%) 36+9
Concomitant therapy (n,%)
Loop diuretics 19 (79%)
ACE-inhibitors 19 (79%)
Beta-blockers 24 (100%)
Spironolactone 15 (63%)
NYHA, New York Heart Association; LV, left ventricular; LVEDV, left ven-
tricular end-diastolic volume; LVESV, left ventricular end-systolic volume;
LVEF, left ventricular ejection fraction.
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Echo IEGM Echo vs. IEGM
median (P25, P75) (ms), mean+SD (ms) median (P25, P75) (ms), mean+SD (ms) weighted Kappa (95% CI)
AV delay (ms) Rest 140 (120–155), 135+28 130 (100–140), 124+21 0.55 (0.31, 0.79)
Exercise 125 (100–140), 128+23 130 (100–140), 126+20 0.64 (0.36, 0.92)
VV delay (ms) Rest 0 (0–0), 26+18 0 (220 to 10), 26+17 0.38 (20.22, 1.0)
Exercise 0 (210 to 0), 23+15 0 (218 to 10), 21+15 0.71 (0.53, 0.89)
AV, atrioventricular interval; VV, interventricular interval; echo, echocardiogram; IEGM, intracardiac electrogram.
Table 3 Optimal VV delay distribution at rest and during exercise, according to echocardiogram and IEGM optimization
VV delay (ms) Echo IEGM
Rest (n,%) Exercise (n,%) Rest (n,%) Exercise (n,%)
Simultaneous 17 (71) 14 (58) 15 (63) 15 (63)
LV pre-activation 5 (21) 6 (25) 9 (37) 7 (29)
RV pre-activation 2 (8) 4 (17) – 2 (8)
VV, interventricular interval; Echo, echocardiogram; IEGM, intracardiac electrogram; LV, left ventricular; RV, right ventricular.
Figure 1 Boxplot (25th–75th percentile), median values (open squares) and outliers (open circles) showing distributions in septal-to-lateral
delay during intrinsic rhythm (without biventricular stimulation) and during cardiac resynchronization therapy with intracardiac electrogram
and echo-optimized atrioventricular and interventricular delays, both at rest and during exercise. IEGM, intracardiac electrogram; ECHO,
echocardiogram; biv, biventricular pacing.
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observed between the echocardiogram and the IEGM
method, both at rest and during exercise. The agreement
in optimizing VV delay between the two methods was fair
at rest, and became stronger during exercise.
Effects of optimized cardiac resynchronization
therapy on left ventricular dyssynchrony at rest
and during exercise
Figure 1 reports septal-to-lateral delay among all patients
during spontaneous rhythm (without biventricular stimu-
lation), and during CRT with IEGM and echo-optimized AV
and VV delays. At rest, median (range) septal-to-lateral
delay during spontaneous rhythm was 65 ms (25–90 ms).
During CRT with the IEGM optimal setting, the delay
decreased to 25 ms, ranging from 15 to 40 ms (P ¼ 0.001).
A similar reduction was observed after the echocardiographic
optimization (P ¼ 0.0003 vs. spontaneous rhythm; P ¼ 0.94
vs. IEGM).
During exercise we observed a shortening in septal-to-
lateral delay during spontaneous rhythm (from 65 ms, range
25–90 ms, to 30 ms, range 13–60 ms, P ¼ 0.006). The delay
further decreased to 18 ms (10–22 ms) during CRT with
the IEGM optimal setting (P ¼ 0.036), and was reduced to
a similar extent by the echocardiographic optimization
(P ¼ 0.001 vs. spontaneous rhythm; P ¼ 0.56 vs. IEGM).
As shown in Figure 2, a signiﬁcant correlation was found
between septal-to-lateral delay measured after the IEGM
and the echocardiographic optimization, both at rest
(r ¼ 0.80; P , 0.0001) and during exercise (r ¼ 0.61;
P ¼ 0.001).
Effects of optimized cardiac resynchronization
therapy on aortic ﬂow at rest and during exercise
Figure 3 shows values of LVOT VTI among all patients during
spontaneous rhythm (without biventricular stimulation), and
during CRTwith IEGM and echo-optimized AV and VV delays.
At rest, median (range) VTI during spontaneous rhythm
was 13.65 cm (11.53–17.92 cm) and increased during CRT
with both the IEGM and the echocardiogram-based setting
(P , 0.0001 vs. spontaneous rhythm for both). A small,
albeit signiﬁcant, difference in LVOT VTI between the two
methods was observed at rest (15.18 cm, range 13.03–
19.82 cm, with IEGM vs. 15.53 cm, range 13.32–20.78 cm,
with echocardiography, P ¼ 0.003), but not during exercise.
Exercise was associated with an increase in LVOT VTI
during spontaneous rhythm (from 13.65 cm, range 11.53–
17.92 cm, to 15.95 cm, range 13.20–19.95 cm, P,0.0001).
Biventricular pacing with the IEGM optimal setting improved
LVOT VTI to 17.08 cm, range 13.72–21.75 cm (P , 0.0001).
A similar increase was induced by the echocardiographic
optimization (P , 0.0001 vs. spontaneous rhythm; P ¼ 0.06
vs. IEGM). Re-assessment of the optimal AV/VV conﬁguration
during exercise by echocardiography was more effective on
LVOT VTI than maintaining the same pacing conﬁguration as
at rest (17.14 cm, range 13.57–21.56 cm, vs. 16.52 cm,
range 13.52–20.75 cm, P , 0.001). Similar results were
found with the IEGM method (P , 0.001).
As shown in Figure 4, a strong linear relationship was
found between LVOT VTI measured after the IEGM and the
echocardiographic optimization, both at rest (r ¼ 0.98;
P , 0.0001) and during exercise (r ¼ 0.99; P ¼ 0.001).
Discussion
This study has shown that in a high proportion of heart
failure patients implanted with a CRT deﬁbrillator, optimal
VV delay differed signiﬁcantly from rest to exercise, while
optimized AV delay did not change. Furthermore, a substan-
tial agreement in optimizing AV delay was observed between
the echocardiogram and the IEGM method. With regard to
VV delay, the agreement between both the optimization
methods was stronger during exercise than at rest. Optimiz-
ation performed during exercise resulted in a shortening of
septal-to-lateral delay and a further increase in haemo-
dynamic parameters, compared with that provided by
resting optimization.
Figure 2 Plot of septal-to-lateral delay after echocardiographic vs. IEGM optimization of atrioventricular and interventricular delays. The
left part refers to rest and the right to exercise. The relative frequencies of the number of data represented by a single plot position are
indicated with circles of varying sizes. IEGM, intracardiac electrogram; ECHO, echocardiogram.
Exercise and CRT optimization 1165Figure 3 Boxplot (25th–75th percentile), median values (A) showing distributions in LVOT VTI during intrinsic rhythm (without biventricular
stimulation) and during cardiac resynchronization therapy with IEGM and echo-optimized atrioventricular and interventricular delays, both
at rest and during exercise. IEGM, intracardiac electrogram; ECHO, echocardiogram; LVOT, left ventricular outﬂow tract; VTI, velocity
time integral; biv, biventricular pacing.
Figure 4 Plot of left ventricular outﬂow tract VTI after echocardiographic vs. IEGM optimization of atrioventricular and interventricular
delay. The left part refers to rest and the right to exercise. IEGM, intracardiac electrogram; ECHO, echocardiogram; VTI, velocity time
integral.
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resynchronization therapy programming
To date, most of the studies on CRT optimization have been
performed in resting conditions, and questions about
optimal CRT programming during exercise are still unre-
solved.
21 In a recent study, Laﬁtte et al. observed
exercise-induced changes in LV dyssynchrony in heart
failure patients (without CRT) undergoing a bicycle exercise
test, thus suggesting that a ﬁxed activation sequence during
biventricular pacing may not be physiological.
14
As regards AV delay, it is still unclear whether it should be
kept constant, shortened or prolonged during exercise, in
order to maximize the haemodynamic beneﬁt. In previous
multicenter CRT trials, a relatively short AV delay was
selected at rest to ensure ventricular capture, and it was
programmed either ﬁxed or with dynamic shortening.
22,23
More recently, Scharf et al. suggested that in CRT patients,
the AV delay should be prolonged at increased heart rates
(20 ms per 10 bpm) to improve the haemodynamic response
to exercise.
15 Studies suggest that in heart failure patients
the dilatation and myocardial stretch of the atria, related
to LV dysfunction and loading conditions, may alter the
intra-atrial conduction pattern.
24 This can be responsible
for the need for ﬁxed or even dynamic lengthening AV
delays in CRT programming. Our results showed no signiﬁ-
cant changes in optimal AV delays from rest to exercise,
whether assessed by echocardiography or IEGM methods.
Similar results were reported by Melzer et al.
25 during sub-
maximal exercise in VDD mode, whereas under DDD stimu-
lation AV delay was found to shorten with increasing heart
rates. Taken together, these ﬁndings seem to support the
use of a ﬁxed AV delay in CRT devices, different from con-
ventional pacemaker systems, in which a rate shortening
AV delay has been shown to improve exercise tolerance.
26
With regard to optimal VV delay, signiﬁcant changes
during exercise were observed in a high proportion of
patients in our study. We could not ﬁnd any concordance
between VV delays optimized at rest and during exercise.
Bordachar et al.
3 reported similar variations in optimal VV
delay in 57% of patients undergoing an echo-guided CRT
optimization during a bicycle test. These ﬁndings can prob-
ably be explained by individual exercise-induced variations
in the ventricular activation pattern. In line with previous
observations,
14 in our study exercise modiﬁed the extent
of intraventricular dyssynchrony, as reﬂected by a shorten-
ing in septal-to-lateral delay during spontaneous rhythm.
This spontaneous improvement in dyssynchrony probably
explains the lack of concordance between resting and exer-
cise optimal VV delays. It is well known that long-term CRT
results in structural remodelling and the optimal pacing con-
ﬁguration tends to vary over time.
27–29 Therefore, we do not
know whether our ﬁndings would be the same after a further
extended period of CRT therapy.
Effects of a cardiac resynchronization therapy
optimization performed during exercise
Several studies have shown that AV and VV delay optimiz-
ation improves LV systolic performance and stroke
volume by decreasing intraventricular and interventricular
dyssynchrony.
6–11 Our study provides further insights into
CRT optimization during exercise. Echocardiogram- and
IEGM-optimized biventricular pacing provided a similar
haemodynamic improvement, compared with spontaneous
rhythm. Importantly, a re-assessment of the optimal
pacing conﬁguration during exercise led to an additional
increase in stroke volume when compared with the resting
optimized setting. The increase in stroke volume was
coupled with a signiﬁcant reduction in intraventricular dys-
synchrony, which was similar in both the IEGM and the stan-
dard echocardiographic optimization. As signiﬁcant changes
in optimal programming were observed for VV, and not for
AV delay, it is conceivable that VV delay re-assessment
during exercise provided the highest additional haemo-
dynamic contribution.
Comparison of echocardiographic vs. intracardiac
electrogram-based optimization
Echocardiography is the most widely adopted method for
CRToptimization,
21 but it is time-consuming, and expertise-
and cost-demanding. Therefore, echocardiographic optimiz-
ation of a CRT device is not routinely performed in practice
and it is often limited only to selected groups of patients
(i.e. patients who do not respond to CRT).
21 In the light of
these considerations, a novel automated programmer-based
method was developed as an alternative to the echocardio-
graphic optimization. The IEGM method recommends the
optimal AV and VV programming based on the analysis of
endocavitary electrograms. The test can be easily per-
formed during routine device follow-up. Previous studies
have documented a good concordance in deﬁning optimal
AV and VV delays at rest between the IEGM and the echo-
based method, with similar acute haemodynamic
effects.
12,13 In the present study, we speciﬁcally aimed to
compare the IEGM and echo-based method not only at
rest, but also during exercise, a condition where an
echo-independent modality of device programming may be
particularly attractive. Of note, this is the ﬁrst study evalu-
ating the feasibility of IEGM optimization during physical
stress. Our results show a good agreement between the
two methods with regard to resting and exercise AV delay
optimization. For VV delay optimization, the degree of con-
cordance was higher during exercise. The differences in pro-
tocol set-up between the two optimization procedures may
account for some discrepancies in deriving optimal VV delay.
In fact, for practical reasons, the echo-guided VV delay
optimization was performed according to a 20 ms stepwise
protocol, in order to limit the number of recordings during
exercise. Conversely, the programmer-based method can
use a 10 ms stepwise protocol. At peak heart rates, the
IEGM optimization provided haemodynamic beneﬁts similar
to the echocardiographic procedure, these ﬁndings further
suggesting that the IEGM method can be considered an
alternative to the standard echocardiographic optimiz-
ation,
12,13,30 with the advantage of being feasible in daily
practice also during a walking or treadmill test.
Clinical implications
The dynamic changes in optimal device programming and
the beneﬁcial effects provided by AV and VV optimization
indicate that re-evaluations of the device parameters at
rest and during exercise may further improve the response
to CRT. Of note, the haemodynamic effects of CRT optimiz-
ation were evaluated in terms of Doppler echocardiographic
parameters, and further studies are required to investigate
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outcome measures. The implementation in CRT devices of
algorithms allowing automatic VV delay optimization
during exercise could be a useful feature, as well as separ-
ate rest–exercise programming options.
Study limitations
AV delay optimization using the IEGM method cannot be per-
formed if there is no measurable atrial activity, for example,
due to severe bradycardia. In the event of complete AV
block, optimal VV timing cannot be determined by the
IEGM algorithm, as intrinsic activation of the LV and RV
chambers is required.
Several echocardiographic methods for AV delay optimiz-
ation are currently used in clinical practice.
21 We optimized
AV delay by evaluating an index of LV systolic function (i.e.
aortic VTI), in line with another study on IEGM optimiz-
ation,
12 and according to previous observations, suggesting
that AV delay optimization provides a greater haemo-
dynamic improvement in CRT patients when guided by the
aortic VTI method, compared with the diastolic ﬁlling time
method.
18 The optimization of AV delay by other echocar-
diographic parameters, evaluating LV diastolic function,
may have led to different results. However, a lack of signiﬁ-
cant changes in sensed AV delay from rest to exercise was
observed by Melzer et al.,
25 by using a combined ECG–
echo method based on diastolic optimization.
Changes in stroke volume were assessed with Doppler
echocardiography. No invasive control was performed.
In line with previous studies,
3–10 a wide inter-individual
variability in optimal VV delay was observed. Simultaneous
biventricular pacing was the most represented optimal
setting, whereas RV pre-activation was suggested by echo
at rest in 8% of the cases, and LV pre-activation only in
21% of patients. Such variations in VV delay may be
related to different patterns of mechanical activation and
LV lead positioning.
9 Since the analysis of LV contraction
pattern, in terms of sites of latest activation, was not per-
formed, the mechanisms underlying different resynchroniza-
tion sequences could not be detailed.
The effects of echo- and IEGM-optimized CRTwere evalu-
ated in relation to spontaneous rhythm (without biventricu-
lar pacing). Likewise, haemodynamic beneﬁts were mainly
related to biventricular pacing, more than to optimization.
However, our aim was not to conﬁrm the beneﬁcial effects
of CRT vs. spontaneous rhythm, but rather to evaluate
whether there are differences between the IEGM- and the
echo-based CRT setting, in terms of dyssynchrony and
aortic ﬂow. Whether AV and VV delay optimization can
provide not only an acute haemodynamic effect, but also a
clinical improvement, is currently unknown.
Conclusion
Signiﬁcant rest–exercise changes in optimal VV delay, but
not in AV delay, were observed in heart failure patients
undergoing CRToptimization according to both the echocar-
diographic and the IEGM method. Re-assessment of optimal
device programming during exercise resulted in an improve-
ment in LV dyssynchrony and haemodynamic parameters,
giving an additional beneﬁt to that provided by a resting
optimization. The IEGM method may be a feasible
alternative to the standard echocardiographic approach
both at rest and during exercise.
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